Tag: High-Impact Chemistry Award

Qing Chen | Analytiacl Chemistry | Best Researcher Award

Published on by World Science Awards

Assist. Prof. Dr. Qing Chen | Analytiacl Chemistry | Best Researcher Award

Shenyang Medical College | China

Dr. Qing Chen is an accomplished Associate Professor at the School of Pharmacy, Shenyang Medical College, China. With a solid academic and research background in analytical chemistry, she has made noteworthy contributions to bio-nanomaterials, precision medicine, and proteomics. She obtained her Ph.D. from the Research Center for Analytical Sciences at Northeastern University, focusing on advanced analytical methodologies for biological applications. Her scientific work bridges multiple disciplines, including chemistry, materials science, and biomedical diagnostics. Dr. Chen is known for her prolific publication record in high-impact journals and active involvement in national and provincial research grants. Her work focuses on the development of nanomaterials for biomolecular separation, targeted drug delivery, and biosensing. With strong collaboration across different research institutions, she has established herself as a promising leader in integrating chemical engineering with clinical problem-solving. Besides her research, Dr. Chen is committed to academic instruction, delivering undergraduate-level chemistry courses and mentoring young scholars. She is a frequent co-author and corresponding author, which highlights her key roles in collaborative projects. Her ability to translate fundamental chemistry into applied health solutions positions her as a valuable contributor to the field of pharmaceutical sciences and a promising candidate for global academic and innovation-based awards.

Professional Profile

Education

Dr. Qing Chen’s academic path reflects a clear trajectory of excellence in chemistry and chemical engineering. She completed her Ph.D. in Analytical Chemistry in January 2018 from the Research Center for Analytical Sciences, College of Sciences, Northeastern University, China, under the supervision of Professor Jianhua Wang. During her doctoral studies, she concentrated on the design and development of novel nanomaterials for biomolecular sensing and separation, laying the foundation for her current research endeavors. Prior to her Ph.D., she earned a Master’s degree in Chemical Engineering from the same university in March 2014, where she was exposed to interdisciplinary research methods and laboratory protocols that integrated chemistry with applied materials. Her undergraduate studies were completed at Liaoning Normal University between 2008 and 2012, where she received a Bachelor of Science in Chemistry. This early foundation provided her with essential knowledge in organic, inorganic, and analytical chemistry, preparing her for a career in academic research and teaching. Across these stages, her education equipped her with a robust framework in experimental design, critical analysis, and data interpretation, all of which are evident in her high-quality publications and research projects. Her academic training remains central to her professional identity as a chemist.

Professional Experience

Dr. Qing Chen has held key academic and research positions that underscore her professional growth and expertise in analytical and pharmaceutical sciences. Since January 2023, she serves as an Associate Professor at the School of Pharmacy, Shenyang Medical College, where she is affiliated with the Shenyang Key Laboratory of Vascular Biology. From April 2018 to December 2022, she worked as a Lecturer at the same institution, where she gradually expanded her research capabilities, supervised student research, and contributed to academic program development. Her teaching portfolio includes foundational courses such as “Organic Chemistry” for medical students and “Chemistry” for international students, fostering a multidisciplinary learning environment. As a researcher, she has led and collaborated on several government-funded projects, including grants from the National Natural Science Foundation of China and the Natural Science Foundation of Liaoning Province. Her research aligns closely with institutional goals to innovate in health sciences and translational medicine. Additionally, her collaboration with clinical and research centers across China enhances her work’s real-world impact. Her professional experience demonstrates a consistent progression in academic responsibility, research depth, and contribution to institutional excellence, reinforcing her profile as a scholar with significant academic and community engagement.

Research Interests

Dr. Qing Chen’s research interests center on the intersection of bio-nanomaterials, precision medicine, and proteomics. Her scientific investigations emphasize the design and development of functionalized nanomaterials for selective molecular detection, protein purification, and drug delivery. By employing metal-organic frameworks (MOFs), polymeric materials, and nanozyme composites, she has successfully created new platforms for diagnosing diseases and understanding biological interactions at the molecular level. One core area of her research is the purification and isolation of proteins and antibodies using modified nanoparticles, which has direct implications in biomarker discovery and therapeutic monitoring. Additionally, her work in proteomics enables the analysis of complex biological samples, contributing to better disease diagnostics and precision treatment strategies. Dr. Chen’s projects often integrate multiple analytical techniques, such as mass spectrometry and optical sensing, to improve sensitivity and selectivity in biomedical assays. Her research addresses real-world health challenges, particularly diabetes, cardiovascular conditions, and antibiotic contamination. As an interdisciplinary scientist, she continuously seeks to bridge chemistry and medicine, focusing on innovations that can translate to clinical diagnostics and environmental health monitoring. Her research is not only scientifically rigorous but also deeply relevant to current and emerging global health needs.

Research Skills

Dr. Qing Chen has developed a comprehensive suite of research skills that support her interdisciplinary investigations in analytical chemistry and pharmaceutical sciences. She is proficient in designing and synthesizing nanomaterials such as metal-organic frameworks (MOFs), magnetic nanoparticles, and polymer composites for biological applications. Her expertise includes a wide range of characterization techniques, including UV/Vis spectrophotometry, infrared spectroscopy, atomic absorption, and advanced chromatography methods. She also utilizes mass spectrometry and electrochemical analysis to validate the performance of her nanomaterial-based detection systems. A core component of her skillset is proteomics, where she specializes in protein isolation, enrichment, and quantitative analysis using targeted and untargeted approaches. Her ability to tailor surface chemistry for specific molecular interactions allows her to design highly selective materials for biosensing and drug delivery. In addition to laboratory techniques, Dr. Chen is skilled in academic writing, grant preparation, and peer-reviewed publishing, with numerous first-author and corresponding-author papers in high-impact journals. She actively mentors undergraduate and graduate students, demonstrating strong skills in research supervision and collaboration. These capabilities make her a valuable contributor to both individual and joint research projects, and they provide her with the flexibility to explore new scientific directions.

Awards and Honors

Dr. Qing Chen’s academic achievements have been recognized through several prestigious grants and funding awards. She was the recipient of the National Natural Science Foundation of China (No. 21804093), supporting her early-stage research in nanomaterials for biomedical applications. In recent years, she has secured continued funding through the Natural Science Foundation of Liaoning Province, including the 2023-MS-324 and 20180550052 projects, highlighting the sustained impact and relevance of her research. She was also awarded the Basic Scientific Research Project of Education Department of Liaoning Province (LJKMZ20221790) and the PhD Start-up Foundation of Liaoning Province (2020-BS-266), both competitive grants that recognize academic excellence and innovation potential. Additionally, Dr. Chen has been acknowledged by her home institution with the Shenyang Excellent Young and Middle-Aged Scientist Project (RC230168), reflecting her influence in shaping future directions in pharmaceutical research. These accolades not only demonstrate the scientific value of her work but also signify her standing as a respected academic within China’s scientific community. Collectively, these awards and honors endorse her role as a forward-looking researcher and affirm her eligibility for further international recognition in science and technology.

Publication Top Notes

  • From simulation to experiment: A Sagnac interference-based double holes optical fiber sensor for ultrasensitive Cu(II) detection, Sensors and Actuators B: Chemical, 2025.

  • Advances in steroid purification for novel techniques in carbon isotope ratio mass spectrometry of doping control, Journal name not specified, 2025.

Conclusion

Dr. Qing Chen stands as a distinguished academic in analytical chemistry with a remarkable record of interdisciplinary research, impactful publications, and sustained academic funding. Her work in nanomaterial development, biosensing, and proteomics demonstrates both innovation and clinical relevance. With over 30 publications in top-tier Q1 journals and consistent involvement in national and provincial-level research projects, she contributes significantly to advancing biomedical diagnostics and drug delivery systems. Her teaching roles further support the training of the next generation of scientists, while her research provides a bridge between academia and real-world health challenges. Dr. Chen’s scientific leadership, combined with her commitment to precision medicine and sustainable healthcare innovation, underscores her potential for international recognition. Looking forward, she is well-positioned to expand her global collaborations, participate in keynote conferences, and join editorial boards that shape the future of analytical and pharmaceutical sciences. Her profile reflects not only past excellence but also a promising trajectory of scientific leadership and innovation that will continue to benefit both academic and societal domains.

Yang Na | Chemistry | Best Researcher Award

Published on by World Science Awards

Dr. Yang Na | Chemistry | Best Researcher Award

Associate professor at University of Electronic Science and Technology of China, China

Dr. Na Yang (b. Jan 1992) is an Associate Professor at the School of Materials and Energy, University of Electronic Science and Technology of China, Chengdu 🇨🇳. She earned her Ph.D. in Chemical Engineering and Technology from Chongqing University and completed postdoctoral research under Prof. Zhongwei Chen at South China Normal University and the University of Waterloo 🇨🇦. Her research focuses on density functional theory (DFT)🧠, ab initio molecular dynamics (AIMD)🧪, catalyst design🧲, and electrochemical mechanisms⚡. With an H-index of 15, Dr. Yang has published in high-impact journals like Angewandte Chemie, Advanced Materials, and ACS Energy Letters 📚. She has contributed significantly to the fields of CO₂ reduction, oxygen reduction reactions, and nitrogen fixation catalysis 🌱.

Publication Profile

Scopus Profile

Research Fields

Dr. Yang Na’s research spans several cutting-edge areas in materials science and energy technology ⚙️⚡. Her primary expertise lies in density functional theory (DFT) and ab initio molecular dynamics (AIMD), which she uses to model and simulate material behavior at the atomic level 🧬💻. She is deeply involved in the design and screening of catalysts for various energy applications, focusing on improving efficiency and stability 🔍🔋. Dr. Yang also works on the preparation of new highly active catalysts, utilizing advanced synthesis techniques to enhance catalytic performance 🧪⚗️. Another key area of her research is the exploration of electrochemical catalytic mechanisms, where she investigates fundamental reaction pathways to optimize energy conversion processes such as hydrogen evolution and oxygen reduction 🌱⚡. Through these interdisciplinary approaches, Dr. Yang contributes significantly to the development of sustainable and high-performance energy materials for a greener future 🌍🔧

🎓 Educational Background

Dr. Yang Na earned her Ph.D. in Chemical Engineering and Technology from Chongqing University, Chongqing, China, where she studied from September 2014 to June 2020 🧪🎓. Under the expert mentorship of Professor Li Li, she developed a strong foundation in advanced chemical engineering principles and materials research 🔬📘. Her doctoral studies involved in-depth exploration of catalyst design, electrochemical energy conversion, and computational modeling, laying the groundwork for her current contributions to energy materials and catalysis research 💡⚙️. The rigorous academic environment at Chongqing University provided her with both theoretical knowledge and hands-on research experience, enabling her to tackle real-world energy challenges with innovative scientific approaches 🌍💻. Dr. Yang’s time at Chongqing University was instrumental in shaping her expertise in computational chemistry, materials synthesis, and electrochemical systems, which continue to define her career as a forward-thinking and impactful researcher in the field of materials science and energy technology ⚛️🔋.

💼 Professional Experience

From September 2020 to September 2022, Dr. Yang Na undertook postdoctoral research that significantly advanced her expertise in materials and energy science 🌱🔬. She began her postdoctoral journey at the School of Information and Optoelectronic Science and Engineering, South China Normal University, Guangdong, China, where she worked under the mentorship of Prof. Zhongwei Chen 📡🧠. During this period, she focused on optoelectronic materials and their applications in energy systems.

Simultaneously, Dr. Yang continued her postdoctoral research at the School of Chemistry and Chemical Engineering, University of Waterloo, Ontario, Canada 🍁⚗️. Under the same mentorship of Prof. Chen, she deepened her research into electrocatalysis and advanced energy storage materials, contributing to cutting-edge developments in sustainable energy technologies 🔋🌍. These international and interdisciplinary experiences enriched her research perspective and equipped her with global insights into innovation and collaboration in the materials science domain 🌐🧪.

Research Focus

Dr. Yang Na specializes in cutting-edge research within the fields of catalysis, energy materials, and sustainable chemistry ⚗️🔋. Her work spans a diverse range of topics including electrocatalysis, chemical looping reforming, CO₂ photoreduction, and ammonia synthesis. Using advanced techniques like density functional theory (DFT) and ab initio molecular dynamics (AIMD), she designs and screens highly active catalysts for clean energy conversion 🌱🌍. Her contributions to perovskite-based and polymer dielectric materials show a strong interdisciplinary approach, connecting materials science, environmental engineering, and green chemistry ♻️🧪. Dr. Yang’s research plays a vital role in promoting efficient energy solutions.

Conclusion

Dr. Yang Na’s exceptional research in renewable energy, particularly her work on catalytic mechanisms and material design for electrochemical reactions, positions her as an outstanding candidate for the “Best Researcher Award.” Her contributions to both theoretical and practical aspects of energy research make her a leader in the field, and her continued work promises to bring lasting impacts to sustainable energy solutions.

Publication Top Notes

  • 🔬 Tailoring active lattice oxygen in CeO₂-Based oxygen carriers for enhanced chemical looping dry reforming of methane – Journal of the Energy Institute, 2025  📄

  • ⚡ NiFe-based arrays with MnO₂ enhance chloride blocking for durable alkaline seawater oxidation – Journal of Colloid and Interface Science, 2025 | 1 citation 💧

  • 🌞 Rational Design of Methylated Triazine-Based Polymers for CO₂ Photoreduction with Water – Advanced Materials, 2025  📘

  • 🧪 Durable, Super-Resilient Polyurethane Elastomers via Hydrogen Bond Cross-Linking – Macromolecules, 2025 🧵

  • 🧫 Axial Cl-Induced Symmetry-Breaking Iron SAC for Electrochemical Ammonia Synthesis – ACS Catalysis, 2025 ⚗️

  • 🔌 All-organic dielectric PP-based polymer with high breakdown strength – Polymer, 2025  ⚡

  • 🧴 Mini-review: Indium-oxide based catalysts for CO₂ to methanol – 2025  📚

  • 💡 Lattice Oxygen Redox in Zeolite-Encapsulated CsPbBr₃ Perovskites for OER – Advanced Science, 2025 🌐

  • 🔄 Real-Time Detection in KNixFe₁₋ₓF₃ Perovskites for Water Oxidation – Small, 2025 | 1 citation 🔍

  • 💧 Water dissociation via bimetallic phosphide & Mn oxide for alkaline HER – Nano Research, 2025  🌊

Ahmet Ozdemir | Medicinal Chemistry | Best Researcher Award

Published on by World Science Awards

Dr Ahmet Ozdemir | Medicinal Chemistry | Best Researcher Award

Professor Doctorate, Anadolu University ,Turkey.

Ahmet ÖZDEMİR, born on July 24, 1972, in Muğla, Turkey, is a Professor of Pharmaceutical Chemistry at Anadolu University, where he has been a faculty member since 1997. He earned his undergraduate degree in Pharmacy from Anadolu University (1990-1994), followed by an M.Sc. in Pharmaceutical Chemistry (1995-1996) and a Ph.D. in the same field (1996-2004), with research focusing on the synthesis and biological activities of novel compounds. Dr. ÖZDEMİR has held various academic positions at Anadolu University, advancing from Research Assistant to Professor. He has also served in administrative roles, including Associate Director of Anadolu University Yunus Emre Vocational School and Vice Academic Director of the Open Education Faculty’s Department of Health Administration. His research is well-regarded, earning him multiple awards, including the Anadolu University Article Performance Award and the ISIF’21 Silver Medal for his work on targeted novel triazolothiadiazine derivatives for lung cancer treatment.

Profile:

Education

Prof. Dr. Ahmet Özdemir’s educational journey began at Salihli Cumhuriyet Elementary School, where he completed his primary education from 1978 to 1983. He continued his secondary education at Salihli 50. Yıl Secondary School from 1983 to 1986, and then attended Salihli High School from 1986 to 1989, where he completed his high school education. Prof. Dr. Özdemir pursued his undergraduate studies at Anadolu University Faculty of Pharmacy, graduating in 1994. He furthered his education with a Master’s Degree in Pharmaceutical Chemistry at Anadolu University’s Graduate School of Health Sciences from 1995 to 1996, where he completed his thesis. He continued at Anadolu University for his Doctoral Degree in Pharmaceutical Chemistry, which he achieved in 2004. Additionally, he possesses intermediate proficiency in English, which complements his academic background and research expertise.

Academic Titles

Prof. Dr. Ahmet Özdemir’s academic career at Anadolu University’s Faculty of Pharmacy spans several roles and achievements. He began his journey as a Research Assistant in 1997, a position he held until 2004. Following this, he advanced to the role of Research Assistant Doctor, continuing his work at the same institution from 2004 to 2005. Dr. Özdemir was then appointed as a Lecturer from 2005 to 2007, showcasing his growing expertise in the field. His contributions were recognized with a promotion to Assistant Professor Doctor, a role he embraced from 2007 to 2010. His exceptional work led to his promotion to Associate Professor Doctor, a position he held from 2010 to 2015. Since 2015, Prof. Dr. Özdemir has served as Professor Doctor, continuing to make significant contributions to the Faculty of Pharmacy and the broader academic community.

Awards

Prof. Dr. Ahmet Özdemir has received several prestigious awards for his academic and research contributions. In 2014, he was honored with the Anadolu University Article Performance Award. His outstanding achievements continued with the Anadolu University Gold Article Performance Award and the Anadolu University Platinum Article Performance Award in 2015. He maintained a high standard of excellence, receiving the Anadolu University Article Performance Award annually from 2016 to 2018. In 2019, Dr. Özdemir was recognized with the Anadolu University Academic Success Award. His consistent performance earned him the Anadolu University Article Performance Award again in 2020. Notably, in 2021, he was awarded the ISIF’21 Silver Medal for the invention titled “Targeted Novel Triazolothiadiazine Derivatives for the Treatment of Lung Cancer” at the 6th Istanbul International Inventions Fair (ISIF’21). This award was shared with Assoc. Prof. Dr. Belgin Sever, Prof. Dr. Mehlika Dilek Altintop, and Prof. Dr. Gülşen Akalın Çiftçi.

Research Focus

Prof. Dr. Ahmet Özdemir’s research is dedicated to the field of medicinal chemistry, with a keen focus on several key areas. He specializes in the synthesis of bioactive compounds, aiming to develop novel chemical entities with potential therapeutic uses, particularly targeting antifungal and antibacterial applications. His work in pharmaceutical chemistry involves investigating the physicochemical properties of these compounds, which has significant implications for drug design and efficacy. Dr. Özdemir also explores antimicrobial agents, focusing on the synthesis and evaluation of compounds designed to combat bacterial and fungal pathogens. In the realm of drug design and development, he examines structure-activity relationships to create effective and selective pharmaceutical agents. Additionally, his contributions extend to invention and innovation, where he develops novel chemical derivatives, such as triazolothiadiazine derivatives, for potential applications in treating diseases like lung cancer.

Publications

  1. “Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy”
    • Authors: Altıntop, M.D., Ertorun, İ., Akalın Çiftçi, G., Özdemir, A.
    • Year: 2024
  2. “Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents”
    • Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
    • Year: 2024
  3. “Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents”
    • Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
    • Year: 2023
  4. “Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy”
    • Authors: Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
    • Year: 2023
  5. “A new series of hydrazones as small-molecule aldose reductase inhibitors”
    • Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
    • Year: 2023
  6. “A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer”
    • Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
    • Year: 2023
  7. “Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action”
    • Authors: Altıntop, M.D., Akalın Çiftçi, G., Yılmaz Savaş, N., Alataş, Ö., Özdemir, A.
    • Year: 2023
  8. “Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency”
    • Authors: Altıntop, M.D., Temel, H.E., Özdemir, A.
    • Year: 2023
  9. “Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer”
    • Authors: Altıntop, M.D., Özdemir, A., Temel, H.E., Kaplancıklı, Z.A., Akalın Çiftçi, G.
    • Year: 2022
  10. “A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition”
    • Authors: Altıntop, M.D., Sever, B., Akalın Çiftçi, G., Alataş, Ö., Özdemir, A.
    • Year: 2022